- Country: USA
- Summary: Performance Enhancing Drug Testing for Navy Drug Demand Reduction Program (DDRP)
- UST Ref No: 118566570
- Deadline: 06 May 2025
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 1301242246
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The contractor shall provide to the Government all labor, materials, facilities, and equipment necessary to analyze the human urine specimens for anabolic steroids as defined in the Designer Anabolic Steroid Control Act of 2014 including subsequent amendments and all performance enhancing substances listed on the Office of the Under Secretary of Defense Memorandum “Department of Defense Special Drug Testing Panel,” April 24, 2024. All testing is under the regulations, directives, policies, and guidelines set forth by the current versions of the Department of Defense (DOD) Drug Demand Reduction Program (DDRP), DOD Instructions 1010.01 (Refer to Attachment 3: Military Personnel Drug Abuse Testing Program) and 1010.16 (Refer to Attachment 4: Technical Procedures for the Military Personnel Drug Abuse Testing Program), the World Anti-Doping Agency Code (WADAC), Article 6, Analysis of Samples (Refer to Attachment 5: World Anti-Doping Agency Code 2021 ) and subsequent revisions. The Contractor shall comply with all current guidelines and procedures and updates as published and distributed by the DOD, WADA, and the Contracting Officer-s Representative (COR).
Please refer to attached Performance Work Statement and Essential Characteristics documents. - Documents:
Essential-Characteristics-PED-testing_NSW.docx
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINPerformance Enhancing Drug Testing for Navy Drug Demand Reduction Program (DDRP) - USA Tender
The DEPT OF DEFENSE | DEPT OF THE NAVY, a Government sector organization in USA, has announced a new tender for Performance Enhancing Drug Testing for Navy Drug Demand Reduction Program (DDRP). This tender is published on USARFP under UST Ref No: 118566570 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-05-06.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
